DFX Intelligence

Data Factory

VentureFirminstitutional vcexempt_reporting_adviser

Canaan Partners

Venture Capital

Stamford, CT

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:ed982cbf-b998-4aea-8740-17e555918ac5

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 6:41 AM UTC and rebuilt at most every 15 minutes.

Relationships: 264
Dated events: 40
On other graphs: 2
Observed: Sep 12, 2026 to Sep 17, 2026
61 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

CANAAN PARTNERS

Registered adviser · cited, shared crd

Allocatorsidentity

Canaan Partners

Manager with allocator commitments · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 41
Vintages: 2012 to 2024
Reported GAV: $5.6Bgross asset value on Form ADV; never dry powder
Funds with fundraising evidence: 0derived
Investments: 151
Portfolio companies: 151
Investments, 12m: 151
Partner-attributed: 0
People: 62
Investment professionals: 61derived
Co-investors: 0derived
LP relationships: 7
Stated sectors: ai,biotech,deep_tech,cybersecurity,quantumas stated by the firm
Latest Form D: Apr 2, 2024
Latest ADV filing: Mar 31, 2026
Website: canaan.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
Canaan Xiii Healthcare Fund L.P.	2024	Early deployment	$0	$106M	1
Canaan Wheelhouse L.P.	2024	Early deployment	$0	$1.0M	0
Canaan Gold Coast L.P.	2024	Early deployment	n/a	$100M	0
Canaan Xiii LP	2024	Early deployment	$0	$650M	2
Canaan Xii LP	2021	Mature	$0	$888M	1
Canaan 2020+ Co-Investment Series 2 LP	2020	Mature	n/a	$21.3M	0
Canaan 2020+ Co-Investment Series 22 LP	2020	Wound down	n/a	$5.0M	0
Canaan 2020+ Co-Investment Series 9 LP	2020	Mature	n/a	$36.8M	0
Canaan 2020+ Co-Investment Series 7 LP	2020	Mature	n/a	$6.5M	0
Canaan 2020+ Co-Investment Series 11 LP	2020	Mature	n/a	$20.1M	0
Canaan 2020+ Co-Investment Series 19 LP	2020	Mature	n/a	$5.0M	0
Canaan 2020+ Co-Investment Series 10 LP	2020	Mature	n/a	$22.2M	0
Canaan 2020+ Co-Investment Series 5 LP	2020	Wound down	n/a	$5.6M	0
Canaan 2020+ Co-Investment Series 3 LP	2020	Mature	n/a	$14.7M	0
Canaan 2020+ Co-Investment Series 20 LP	2020	Mature	n/a	$7.8M	0
Canaan 2020+ Co-Investment Series 18 LP	2020	Mature	n/a	$14.0M	0
Canaan 2020+ Co-Investment Series 13 LP	2020	Mature	n/a	$9.8M	0
Canaan 2020+ Co-Investment Series 21 LP	2020	Mature	n/a	$7.3M	0
Canaan 2020+ Co-Investment Series 17 LP	2020	Mature	n/a	$6.3M	0
Canaan 2020+ Co-Investment Series 6 LP	2020	Mature	n/a	$12.7M	0
Canaan 2020+ Co-Investment Series 14 LP	2020	Mature	n/a	$5.0M	0
Canaan 2020+ Co-Investment Series 12 LP	2020	Mature	n/a	$11.0M	0
Canaan 2020+ Co-Investment Series 8 LP	2020	Mature	n/a	$1.0M	0
Canaan 2020+ Co-Investment Series 15 LP	2020	Mature	n/a	$9.6M	0
Canaan 2020+ Co-Investment Series 4 LP	2020	Mature	n/a	$1.4M	0

Investments

round size is never this investor's check

Company	State	Stage	Round size	Partner	Attribution	Observed
Active Network	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
ActualyzeAI, Inc	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Advanced BioHealing	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aer Therapeutics, Inc.	Nc	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aeva NYSE (AEVA)	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Agomab Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Aim Security	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
AirEye	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Alkymi	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Alphina Therapeutics, Inc.	Ct	n/a	n/a	n/a	Unknown	Sep 16, 2026
Alsius Corporation	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
AlterEgo Networks	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Alterome Therapeutics, Inc	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Altimate Inc	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Ambra Health	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Amicus Therapeutics	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Antiva Biosciences, Inc.	CA	n/a	n/a	n/a	Unknown	Sep 16, 2026
Apartment List	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Apieron	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Appsmith	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Arbor	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Arbor Networks	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Arcade	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Archipelago	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026
Actio Biosciences, Inc.	n/a	n/a	n/a	n/a	Unknown	Sep 16, 2026

Co-investors

pairs come only from shared rounds and listings

Investor	Co-investor	Shared deals	Shared companies	Last observed	Strength
Nyca Management LLC	Canaan Partners	3	3	Sep 16, 2026	Recurring
Pappas Ventures	Canaan Partners	3	3	Sep 16, 2026	Recurring
Canaan Partners	RA Capital Management, LP	2	2	Sep 16, 2026	Recurring
Grdnt LLC	Canaan Partners	2	2	Sep 16, 2026	Recurring
Nightdragon Management Company, LLC	Canaan Partners	2	2	Sep 16, 2026	Recurring
Canaan Partners	Great Oaks Management Company LLC	2	2	Sep 16, 2026	Recurring
Beliade	Canaan Partners	2	2	Sep 16, 2026	Recurring
mark vc	Canaan Partners	2	2	Sep 16, 2026	Recurring
Asset Management Ventures, LLC	Canaan Partners	2	2	Sep 16, 2026	Recurring
Dcvc	Canaan Partners	2	2	Sep 16, 2026	Recurring
FJ Labs	Canaan Partners	2	2	Sep 16, 2026	Recurring
Accel	Canaan Partners	2	2	Sep 16, 2026	Recurring
Westly Group	Canaan Partners	2	2	Sep 16, 2026	Recurring
Standard Capital Ventures	Canaan Partners	1	1	Sep 16, 2026	One time
Biogeneration III Services B.V.	Canaan Partners	1	1	Sep 16, 2026	One time

Relationships

showing 80 of 264

Invested in (80)

→ AlterEgo NetworksCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ BellhopCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AbyrxCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Alsius CorporationCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ArcadeCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ BeckonCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ HomeisCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Immunicon CorporationCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Advanced BioHealingCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Alphina Therapeutics, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Amicus TherapeuticsCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Arbor NetworksCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ArvinasCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Basebuild, IncCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ GenVecCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Hermeus CorpCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ HugoCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Hyalex Orthopaedics, Inc.CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ EnpirionCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ActualyzeAI, IncCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Aeva NYSE (AEVA)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AlkymiCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ForteCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Ambra HealthCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Apartment ListCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ArborCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ArchipelagoCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ ArtieCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ Astra NASDAQ (ASTR)CompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
→ AziboCompanyPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
and 50 more

Dated events

35 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Dec 31, 2025
LP commitment disclosed
CalPERS reports Canaan Gold Coast L.P.: $235,000,000 committed, vintage 2023, net IRR 66.8%, 1.8x
California Public Employees' Retirement System Plan disclosureobserved 7 days ago
$235M
Occurred
Nov 1, 2025
Person joined
Laura Chau joined Schedule A of Canaan Partners as Manager Of Canaan Partners Xiii Llc
Form ADVobserved 5 days ago
Occurred
Mar 31, 2022
Person left
Eric Young (Manager Of Canaan Partners Viii Llc) no longer on Schedule A of Canaan Partners
Form ADVobserved 7 days ago
Occurred
Mar 30, 2021
Person left
Daniel Ciporin (Manager Of Canaan Partners Xi Llc) no longer on Schedule A of Canaan Partners
Form ADVobserved 7 days ago
Occurred
Mar 30, 2021
Person left
Gregory Kopchinsky (Manager Of Canaan Partners Vii Llc) no longer on Schedule A of Canaan Partners
Form ADVobserved 7 days ago

Show 35 bookkeeping events

First seen by DFX
Sep 15, 2026
date not stated
Halda Therapeutics, LLC: acquired by Johnson & Johnson on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
First seen by DFX
Sep 15, 2026
date not stated
Dragos Majority Stake: acquired by Accenture on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
First seen by DFX
Sep 15, 2026
date not stated
Actio Biosciences, Inc.: acquired by Jazz Pharmaceuticals on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
First seen by DFX
Sep 15, 2026
date not stated
Aim Security: acquired by Cato Networks on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
First seen by DFX
Sep 15, 2026
date not stated
Ambra Health: acquired by Intelerad on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
First seen by DFX
Sep 15, 2026
date not stated
Axis Security: acquired by HP Enterprise on or before 2026-09-15 (no date published), per Canaan Partners's portfolio page
Occurred
Jun 11, 2024
Canaan Xiii Healthcare Fund L.P. first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $105,952,756
Occurred
Mar 28, 2024
Canaan Gold Coast L.P. first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $100,231,573
Occurred
Mar 28, 2024
Canaan 2020+ Co-Investment Series 22 LP no longer reported on Form ADV by Canaan Partners
Occurred
Mar 28, 2024
Canaan 2020+ Co-Investment Series 5 LP no longer reported on Form ADV by Canaan Partners
Occurred
Mar 28, 2024
Canaan Wheelhouse L.P. first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $1,034,929
Occurred
Mar 28, 2024
Canaan Xiii LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $650,000,000
Occurred
Mar 31, 2023
Canaan 2020+ Co-Investment Series 22 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $5,000,000
Occurred
Mar 31, 2023
Canaan 2020+ Co-Investment Series 21 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $7,000,000
Occurred
Mar 31, 2023
Canaan 2020+ Co-Investment Series 19 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $5,000,000
Occurred
Mar 31, 2023
Canaan 2020+ Co-Investment Series 20 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $7,900,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 7 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $16,400,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 15 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $6,549,407
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 16 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $15,021,154
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 17 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $5,000,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 18 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $14,000,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 14 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $5,000,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 6 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $17,000,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 5 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $18,100,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 8 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $14,999,998
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 4 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $13,147,397
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 9 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $45,673,959
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 10 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $16,920,803
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 11 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $27,250,182
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 12 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $11,035,000
Occurred
Mar 31, 2022
Canaan 2020+ Co-Investment Series 13 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $5,088,000
Occurred
Mar 30, 2021
Canaan 2020+ Co-Investment Series 3 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $24,999,988
Occurred
Mar 30, 2021
Canaan Xii LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $800,000,000
Occurred
Mar 30, 2021
Canaan 2020+ Co-Investment Series 2 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $30,101,092
Occurred
Mar 30, 2021
Canaan 2020+ Co-Investment Series 1 LP first reported on Form ADV by Canaan Partners (Venture Capital Fund), GAV $24,000,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 2 work emails (firm website) · as of 2026-09-17

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:ed982cbf-b998-4aea-8740-17e555918ac5
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 2 days ago
Source families: Federal regulator filings, Firm and issuer disclosures
4 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Canaan Partners

Venture Capital

Stamford, CT

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:ed982cbf-b998-4aea-8740-17e555918ac5

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 20, 2026, 6:41 AM UTC and rebuilt at most every 15 minutes.

Fund

Vintage

Lifecycle

Form D sold

GAV

LPs

Canaan Xiii Healthcare Fund L.P.

2024

Early deployment

$106M

Canaan Wheelhouse L.P.

2024

Early deployment

$1.0M

Canaan Gold Coast L.P.

2024

Early deployment

n/a

$100M

Canaan Xiii LP

2024

Early deployment

$650M

Canaan Xii LP

2021

Mature

$888M

Canaan 2020+ Co-Investment Series 2 LP

2020

Mature

n/a

$21.3M

Canaan 2020+ Co-Investment Series 22 LP

2020

Wound down

n/a

$5.0M

Canaan 2020+ Co-Investment Series 9 LP

2020

Mature

n/a

$36.8M

Canaan 2020+ Co-Investment Series 7 LP

2020

Mature

n/a

$6.5M

Canaan 2020+ Co-Investment Series 11 LP

2020

Mature

n/a

$20.1M

Canaan 2020+ Co-Investment Series 19 LP

2020

Mature

n/a

$5.0M

Canaan 2020+ Co-Investment Series 10 LP

2020

Mature

n/a

$22.2M

Canaan 2020+ Co-Investment Series 5 LP

2020

Wound down

n/a

$5.6M

Canaan 2020+ Co-Investment Series 3 LP

2020

Mature

n/a

$14.7M

Canaan 2020+ Co-Investment Series 20 LP

2020

Mature

n/a

$7.8M

Canaan 2020+ Co-Investment Series 18 LP

2020

Mature

n/a

$14.0M

Canaan 2020+ Co-Investment Series 13 LP

2020

Mature

n/a

$9.8M

Canaan 2020+ Co-Investment Series 21 LP

2020

Mature

n/a

$7.3M

Canaan 2020+ Co-Investment Series 17 LP

2020

Mature

n/a

$6.3M

Canaan 2020+ Co-Investment Series 6 LP

2020

Mature

n/a

$12.7M

Canaan 2020+ Co-Investment Series 14 LP

2020

Mature

n/a

$5.0M

Canaan 2020+ Co-Investment Series 12 LP

2020

Mature

n/a

$11.0M

Canaan 2020+ Co-Investment Series 8 LP

2020

Mature

n/a

$1.0M

Canaan 2020+ Co-Investment Series 15 LP

2020

Mature

n/a

$9.6M

Canaan 2020+ Co-Investment Series 4 LP

2020

Mature

n/a

$1.4M

Company

State

Stage

Round size

Partner

Attribution

Observed

Active Network

n/a

Unknown

Sep 16, 2026

ActualyzeAI, Inc

n/a

Unknown

Sep 16, 2026

Advanced BioHealing

n/a

Unknown

Sep 16, 2026

Aer Therapeutics, Inc.

n/a

Unknown

Sep 16, 2026

Aeva NYSE (AEVA)

n/a

Unknown

Sep 16, 2026

Agomab Therapeutics

n/a

Unknown

Sep 16, 2026

Aim Security

n/a

Unknown

Sep 16, 2026

AirEye

n/a

Unknown

Sep 16, 2026

Alkymi

n/a

Unknown

Sep 16, 2026

Alphina Therapeutics, Inc.

n/a

Unknown

Sep 16, 2026

Alsius Corporation

n/a

Unknown

Sep 16, 2026

AlterEgo Networks

n/a

Unknown

Sep 16, 2026

Alterome Therapeutics, Inc

n/a

Unknown

Sep 16, 2026

Altimate Inc

n/a

Unknown

Sep 16, 2026

Ambra Health

n/a

Unknown

Sep 16, 2026

Amicus Therapeutics

n/a

Unknown

Sep 16, 2026

Antiva Biosciences, Inc.

n/a

Unknown

Sep 16, 2026

Apartment List

n/a

Unknown

Sep 16, 2026

Apieron

n/a

Unknown

Sep 16, 2026

Appsmith

n/a

Unknown

Sep 16, 2026

Arbor

n/a

Unknown

Sep 16, 2026

Arbor Networks

n/a

Unknown

Sep 16, 2026

Arcade

n/a

Unknown

Sep 16, 2026

Archipelago

n/a

Unknown

Sep 16, 2026

Actio Biosciences, Inc.

n/a

Unknown

Sep 16, 2026

Investor

Co-investor

Shared deals

Shared companies

Last observed

Strength

Nyca Management LLC

Canaan Partners

Sep 16, 2026

Recurring

Pappas Ventures

Canaan Partners

Sep 16, 2026

Recurring

Canaan Partners

RA Capital Management, LP

Sep 16, 2026

Recurring

Grdnt LLC

Canaan Partners

Sep 16, 2026

Recurring

Nightdragon Management Company, LLC

Canaan Partners

Sep 16, 2026

Recurring

Canaan Partners

Great Oaks Management Company LLC

Sep 16, 2026

Recurring

Beliade

Canaan Partners

Sep 16, 2026

Recurring

mark vc

Canaan Partners

Sep 16, 2026

Recurring

Asset Management Ventures, LLC

Canaan Partners

Sep 16, 2026

Recurring

Dcvc

Canaan Partners

Sep 16, 2026

Recurring

FJ Labs

Canaan Partners

Sep 16, 2026

Recurring

Accel

Canaan Partners

Sep 16, 2026

Recurring

Westly Group

Canaan Partners

Sep 16, 2026

Recurring

Standard Capital Ventures

Canaan Partners

Sep 16, 2026

One time

Biogeneration III Services B.V.

Canaan Partners

Sep 16, 2026

One time